The illegal diversion of prescription medication is a serious threat to public safety. Over the past decade there has been a significant increase in the proportion of Americans treated for prescription painkiller abuse. At the Harvard Drug Group, we have pledged to make battling this growing problem a top priority. We understand that truly reducing this problem will require the collaboration of manufacturers, distributors, healthcare professionals and regulatory officials. Through our Reducing Illegal Diversion initiative, we are dedicated to providing the latest information and tools to help make a positive impact.